fbpx Skip to content


More than 1,000 eye care professionals worldwide have been using the AdaptDx® and AdaptDx Pro® to test for impaired dark adaptation, the earliest biomarker of age-related macular degeneration. Our customers tell the story of how they’re fighting against preventable blindness by identifying AMD at its earliest stages and closely monitoring its progression. 

One of the great things about the AdaptDx is that it’s a very straightforward test to understand as a practitioner. It’s basically a yes-or-no test. If somebody has impaired dark adaptation, which means their ability to recover from a bright light takes longer than 6.5 minutes, we know with 90% sensitivity and specificity that the patient may have macular degeneration.

dierker Damon Dierker, OD

Having had the AdaptDx in my practice for almost 5 years has reinforced my confidence level in diagnosing AMD early with 90% sensitivity and specificity. My patients appreciate this technology and early diagnosis so that we can better monitor their progress and guide them with preventive measures. My patients recognize our practice as an AMD Center of Excellence with a commitment to preventing blindness through early diagnosis and management. MacuLogix has given our doctors the tool to be leaders in early AMD diagnosis.

Glen Corbin, OD Glenn S. Corbin, OD

Practices that have diversified into managing AMD are some of the most successful in the country and are well-positioned for the future.

Paul M. Karpecki, OD, FAAO Paul Karpecki, OD

The AdaptDx gives us the best gift of all: time to take appropriate action to slow the progression of the disease. All in all, this instrument is crucial in the early detection & disease management of AMD.

JoshuaMcDaniel (2) Joshua J. McDaniel

The MacuLogix AdaptDx performs a robust and reliable test of central retinal function and helps identify an early biomarker for age-related macular degeneration. The elegance of the instrument lies in its simplicity: an easy procedure for the patient, a short test duration, and an unambiguous data output for the clinician.

LarryBaitch Larry Baitch, OD

The AdaptDx has been a wonderful addition to our practice. Not only does it allow us to help detect macular degeneration at its earliest subclinical state, but also allows us to help educate patients about lifestyle changes. The whole goal is to delay advancement of the disease and improve the quality of living. It has been a wonderful practice builder by setting us apart as a very high-quality eye care facility providing better patient confidence in the care that they are being provided.

MichaelFishbaugh Michael Fishbaugh, OD

Using the AdaptDx, doctors can help patients with one of the most feared conditions and provide them hope and early treatment options.

Paul M. Karpecki, OD, FAAO Paul Karpecki, OD

I am excited that my practice can now work toward the goal of eliminating vision loss from macular degeneration by proactively identifying this disease early and providing earlier intervention for our patients. Our AdaptDx sits next to our visual field and OCT. Our practice is now prepared to identify and manage macular degeneration the same way we do glaucoma.

RyanPowell Ryan Powell, OD

The MacuLogix AdaptDx dark adaptometer is the first device of its kind that will provide me with a quantifiable result that can be monitored over time. It allows me to track the function of a patient’s macular rod photoreceptors, which is a very specific biomarker for AMD. In my opinion, this device is a game-changer in any practice committed to preserving sight. Having the ability to diagnose AMD in patients with symptoms but little to no clinical signs has taken my confidence to the next level.

TimothyEarley (2) Timothy Earley, OD

Equipment companies usually ship you a big box and you never hear from them again. That was not the case with MacuLogix and their AdaptDx. They spent 2 days with us and did a fantastic job training our whole office!

Julia Blank OD Julia Blank, OD